Literature DB >> 18358600

Sensitization of cerebral tissue in nude mice with photodynamic therapy induces ADAM17/TACE and promotes glioma cell invasion.

Xuguang Zheng1, Feng Jiang, Mark Katakowski, Xuepeng Zhang, Hao Jiang, Zheng Gang Zhang, Michael Chopp.   

Abstract

In the present study, we tested the hypothesis that a mild cerebral tissue injury promotes subsequent glioma invasion via activation of the ADAM17-EGFR-PI3K-Akt pathway. Mild injury was induced by photodynamic therapy (PDT), which employs tissue-penetrating laser light exposure following systemic administration of a tumor-localizing photosensitizer. Athymic nude mice were treated with sublethal PDT (80 J/cm2 with 2 mg/kg Photofrin). Hypoxic stress and ADAM17-EGFR-PI3K-Akt were measured using Western blot and immunostaining. Additional groups with/without pro-sublethal PDT were subsequently implanted with U87 glioma tumor cell. Tumor invasion and ADAM17-EGFR-PI3K-Akt pathway in tumor area were measured. After a sublethal dose of PDT, HIF-1alpha expression was increased by a factor of three in PDT-treated normal brain tissue compared to contralateral control brain tissue. PDT-treated brain tissue exhibited a significant increase in ADAM17, p-EGFR, p-Akt expression compared to non-treated tissue. ADAM17 positive area significantly increased from 1.78% to 10.89%. The percentage of p-EGFR and p-Akt positive cells significantly increased from 9.50% and 14.50% to 21.31% and 32.29%, respectively, PDT treatment significantly increased subsequent implanted U87 glioma cell invasion by 3.68-fold and increased ADAM17, EGFR, p-EGFR, Akt, p-Akt expression by 178%, 43.9%, 152.7%, 89.6%,and 164.2%, respectively, compared to control group. Our data showed that a sublethal sensitization of cerebral tissue with PDT significantly increased U87 cell invasion in nude mice, and that glioma cell invasion is highly correlated with activation of the ADAM17-EGFR-PI3K-Akt pathway (r=0.928, 0.775, 0.870, 0.872, and 0.883, respectively), most likely via HIF-1alpha.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18358600      PMCID: PMC2432085          DOI: 10.1016/j.canlet.2008.02.023

Source DB:  PubMed          Journal:  Cancer Lett        ISSN: 0304-3835            Impact factor:   8.679


  50 in total

1.  Oxygen consumption and diffusion effects in photodynamic therapy.

Authors:  T H Foster; R S Murant; R G Bryant; R S Knox; S L Gibson; R Hilf
Journal:  Radiat Res       Date:  1991-06       Impact factor: 2.841

2.  Hypoxia-mediated stimulation of carcinoma cell invasiveness via upregulation of urokinase receptor expression.

Authors:  C H Graham; J Forsdike; C J Fitzgerald; S Macdonald-Goodfellow
Journal:  Int J Cancer       Date:  1999-02-09       Impact factor: 7.396

3.  Differential gene expression analysis reveals generation of an autocrine loop by a mutant epidermal growth factor receptor in glioma cells.

Authors:  Deepti B Ramnarain; Seongmi Park; Diana Y Lee; Kimmo J Hatanpaa; Shane O Scoggin; Hasan Otu; Towia A Libermann; Jack M Raisanen; Raheela Ashfaq; Eric T Wong; Julian Wu; Robert Elliott; Amyn A Habib
Journal:  Cancer Res       Date:  2006-01-15       Impact factor: 12.701

4.  Ectodomain shedding of TGF-alpha and other transmembrane proteins is induced by receptor tyrosine kinase activation and MAP kinase signaling cascades.

Authors:  H Fan; R Derynck
Journal:  EMBO J       Date:  1999-12-15       Impact factor: 11.598

5.  Cytostatic Agents in the Management of Malignant Gliomas.

Authors: 
Journal:  Cancer Control       Date:  1998-03       Impact factor: 3.302

6.  Cannabinoids induce cancer cell proliferation via tumor necrosis factor alpha-converting enzyme (TACE/ADAM17)-mediated transactivation of the epidermal growth factor receptor.

Authors:  Stefan Hart; Oliver M Fischer; Axel Ullrich
Journal:  Cancer Res       Date:  2004-03-15       Impact factor: 12.701

7.  Mutant epidermal growth factor receptor up-regulates molecular effectors of tumor invasion.

Authors:  Anita Lal; Chad A Glazer; Holly M Martinson; Henry S Friedman; Gary E Archer; John H Sampson; Gregory J Riggins
Journal:  Cancer Res       Date:  2002-06-15       Impact factor: 12.701

8.  Hydroxamate-based metalloprotease inhibitor blocks shedding of L-selectin adhesion molecule from leukocytes: functional consequences for neutrophil aggregation.

Authors:  T A Bennett; E B Lynam; L A Sklar; S Rogelj
Journal:  J Immunol       Date:  1996-05-01       Impact factor: 5.422

9.  A metalloprotease inhibitor blocks shedding of the 80-kD TNF receptor and TNF processing in T lymphocytes.

Authors:  P D Crowe; B N Walter; K M Mohler; C Otten-Evans; R A Black; C F Ware
Journal:  J Exp Med       Date:  1995-03-01       Impact factor: 14.307

10.  Analysis of acute vascular damage after photodynamic therapy using benzoporphyrin derivative (BPD).

Authors:  V H Fingar; P K Kik; P S Haydon; P B Cerrito; M Tseng; E Abang; T J Wieman
Journal:  Br J Cancer       Date:  1999-04       Impact factor: 7.640

View more
  18 in total

Review 1.  The role of epidermal growth factor receptor in photodynamic therapy: a review of the literature and proposal for future investigation.

Authors:  Pedro A Martínez-Carpio; Mario A Trelles
Journal:  Lasers Med Sci       Date:  2010-06-10       Impact factor: 3.161

2.  ADAM17 promotes glioma cell malignant phenotype.

Authors:  Xuguang Zheng; Feng Jiang; Mark Katakowski; Yong Lu; Michael Chopp
Journal:  Mol Carcinog       Date:  2011-04-07       Impact factor: 4.784

3.  TGF-β1 promotes motility and invasiveness of glioma cells through activation of ADAM17.

Authors:  Yong Lu; Feng Jiang; Xuguang Zheng; Mark Katakowski; Benjamin Buller; Shing-Shun Tony To; Michael Chopp
Journal:  Oncol Rep       Date:  2011-02-24       Impact factor: 3.906

4.  ADAM17 mediates hypoxia-induced drug resistance in hepatocellular carcinoma cells through activation of EGFR/PI3K/Akt pathway.

Authors:  Xiang-Jun Wang; Chang-Wei Feng; Min Li
Journal:  Mol Cell Biochem       Date:  2013-04-28       Impact factor: 3.396

5.  On the role of phosphatidylinositol 3-kinase, protein kinase b/Akt, and glycogen synthase kinase-3β in photodynamic injury of crayfish neurons and glial cells.

Authors:  Maxim A Komandirov; Evgeniya A Knyazeva; Yulia P Fedorenko; Mikhail V Rudkovskii; Denis A Stetsurin; Anatoly B Uzdensky
Journal:  J Mol Neurosci       Date:  2011-02-12       Impact factor: 3.444

6.  Gallic acid suppresses cell viability, proliferation, invasion and angiogenesis in human glioma cells.

Authors:  Yong Lu; Feng Jiang; Hao Jiang; Kalina Wu; Xuguang Zheng; Yizhong Cai; Mark Katakowski; Michael Chopp; Shing-Shun Tony To
Journal:  Eur J Pharmacol       Date:  2010-06-08       Impact factor: 4.432

7.  TP53 regulates human AlkB homologue 2 expression in glioma resistance to Photofrin-mediated photodynamic therapy.

Authors:  S Y Lee; S K Luk; C P Chuang; S P Yip; S S T To; Y M B Yung
Journal:  Br J Cancer       Date:  2010-07-27       Impact factor: 7.640

8.  ADAM17 promotes breast cancer cell malignant phenotype through EGFR-PI3K-AKT activation.

Authors:  Xuguang Zheng; Feng Jiang; Mark Katakowski; Zheng Gang Zhang; Qing-e Lu; Michael Chopp
Journal:  Cancer Biol Ther       Date:  2009-06-25       Impact factor: 4.742

9.  Dihydroartemisinin suppresses glioma proliferation and invasion via inhibition of the ADAM17 pathway.

Authors:  Junyan Chen; Xiangrong Chen; Fan Wang; Hongzhi Gao; Weipeng Hu
Journal:  Neurol Sci       Date:  2014-10-10       Impact factor: 3.307

10.  Transcription factor Sp1 induces ADAM17 and contributes to tumor cell invasiveness under hypoxia.

Authors:  Alexandra Szalad; Mark Katakowski; Xuguang Zheng; Feng Jiang; Michael Chopp
Journal:  J Exp Clin Cancer Res       Date:  2009-09-22
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.